600873 梅花生物
按盤價 
10.220 -0.040 (-0.390%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 19.713 | 19.072 | 22.985 | 36.432 | 24.316 |
| 總資產報酬率 ROA (%) | 12.149 | 11.670 | 13.352 | 19.381 | 12.019 |
| 投入資產回報率 ROIC (%) | 13.842 | 13.284 | 15.318 | 22.413 | 13.947 | 邊際利潤分析 |
| 銷售毛利率 (%) | 21.264 | 20.075 | 19.681 | 25.133 | 19.406 |
| 營業利潤率 (%) | 14.597 | 13.927 | 13.737 | 18.471 | 12.703 |
| 息稅前利潤/營業總收入 (%) | 18.822 | 12.893 | 13.291 | 18.744 | 13.271 |
| 淨利潤/營業總收入 (%) | 16.607 | 10.931 | 11.459 | 15.772 | 10.526 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 69.157 | 95.737 | 96.746 | 96.008 | 91.576 |
| 價值變動淨收益/利潤總額(%) | 1.959 | 1.344 | -0.819 | 1.107 | 9.915 |
| 營業外收支淨額/利潤總額(%) | 22.762 | -4.234 | -2.424 | -0.143 | -1.596 | 償債能力分析 |
| 流動比率 (X) | 1.290 | 1.196 | 1.456 | 1.486 | 1.354 |
| 速動比率 (X) | 1.005 | 0.830 | 1.009 | 0.876 | 0.819 |
| 資產負債率 (%) | 37.995 | 38.785 | 38.840 | 44.813 | 49.128 |
| 帶息債務/全部投入資本 (%) | 27.689 | 27.983 | 28.287 | 33.076 | 38.454 |
| 股東權益/帶息債務 (%) | 254.708 | 249.687 | 245.454 | 193.365 | 152.614 |
| 股東權益/負債合計 (%) | 163.190 | 157.830 | 157.469 | 123.151 | 103.550 |
| 利息保障倍數 (X) | -245.697 | -27.563 | -110.382 | 62.433 | 17.296 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 8.585 | 8.825 | 6.367 | 4.004 | 4.181 |
| 存貨周轉天數 (天) | 46.108 | 50.710 | 56.437 | 60.763 | 50.502 |
| 備註： | 即時報價更新時間為 29/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
